Brian Joseph Kieser bought Nexgel stock
By AlphaYouPublished Form 4
Kieser Brian Joseph
Reporting filer
Brian Joseph Kieser reported buying Nexgel, Inc. stock. Form 4 filed Nov 14, 2026 lists 10 entries.
See the price move since this trade →
- Disclosed
- Nov 14, 2026
Reported details
10 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kieser Brian Joseph | 2026-11-10 | P | Purchase | 133216 | 5.50 | 133,216 | 4 days | Filed terms
|
| Warrant to Purchase Common Stock (the "PIPE Warrant") (derivative) | Kieser Brian Joseph | 2026-11-10 | P | Purchase | 133216 | 0.00 | 133,216 | 4 days | Filed terms
|
| Convertible Promissory Note (before amendment) (derivative) | Kieser Brian Joseph | 2026-11-10 | D | Disposition to issuer | 83334 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
| Convertible Promissory Note (as amended) (derivative) | Kieser Brian Joseph | 2026-11-10 | A | Grant or award | 181819 | Not stated (see footnotes) | 181,819 | 4 days | Filed terms
|
| Warrant to Purchase Common Stock (derivative) | Kieser Brian Joseph | 2026-11-10 | D | Disposition to issuer | 41667 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
| Existing Warrant (as amended) (derivative) | Kieser Brian Joseph | 2026-11-10 | A | Grant or award | 41667 | Not stated (see footnotes) | 41,667 | 4 days | Filed terms
|
| Convertible Promissory Note (before amendment) (derivative) | Kieser Brian Joseph | 2026-11-10 | D | Disposition to issuer | 458334 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
| Convertible Promissory Note (as amended) (derivative) | Kieser Brian Joseph | 2026-11-10 | A | Grant or award | 1000000 | Not stated (see footnotes) | 1,000,000 | 4 days | Filed terms
|
| Existing Warrant (before amendment) (derivative) | Kieser Brian Joseph | 2026-11-10 | D | Disposition to issuer | 229167 | Not stated (see footnotes) | 0 | 4 days | Filed terms
|
| Existing Warrant (as amended) (derivative) | Kieser Brian Joseph | 2026-11-10 | A | Grant or award | 229167 | Not stated (see footnotes) | 229,167 | 4 days | Filed terms
|
Common Stock
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- P
- Action
- Purchase
- Quantity
- 133216
- Price
- 5.50
- Following holdings
- 133,216
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 133216
- transaction Price Per Share: 5.50
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 133216
- id: F2
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sequence LifeScience, Inc.
- id: F5
Warrant to Purchase Common Stock (the "PIPE Warrant") (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- P
- Action
- Purchase
- Quantity
- 133216
- Price
- 0.00
- Following holdings
- 133,216
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Warrant to Purchase Common Stock (the "PIPE Warrant")
- id: F1
- id: F5
- conversion Or Exercise Price: 10.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 133216
- transaction Price Per Share: 0.00
- id: F1
- transaction Acquired Disposed Code: A
- exercise Date: 2026-11-10
- expiration Date: 2031-11-10
- underlying Security Title: Common Stock
- underlying Security Shares: 133216
- shares Owned Following Transaction: 133216
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sequence LifeScience, Inc.
- id: F5
Convertible Promissory Note (before amendment) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 83334
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Convertible Promissory Note (before amendment)
- id: F3
- conversion Or Exercise Price: 12.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 83334
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-05-11
- expiration Date: 2027-11-11
- underlying Security Title: Common Stock
- underlying Security Shares: 83334
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Convertible Promissory Note (as amended) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- A
- Action
- Grant or award
- Quantity
- 181819
- Price
- Not stated (see footnotes)
- Following holdings
- 181,819
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Convertible Promissory Note (as amended)
- id: F3
- id: F4
- conversion Or Exercise Price: 5.50
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 181819
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-05-11
- expiration Date: 2027-11-11
- underlying Security Title: Common Stock
- underlying Security Shares: 181819
- shares Owned Following Transaction: 181819
- direct Or Indirect Ownership: D
Warrant to Purchase Common Stock (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 41667
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Warrant to Purchase Common Stock
- conversion Or Exercise Price: 16.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 41667
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-05-11
- expiration Date: 2031-05-11
- underlying Security Title: Common Stock
- underlying Security Shares: 41667
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Existing Warrant (as amended) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- A
- Action
- Grant or award
- Quantity
- 41667
- Price
- Not stated (see footnotes)
- Following holdings
- 41,667
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Existing Warrant (as amended)
- id: F3
- conversion Or Exercise Price: 13.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 41667
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-05-11
- expiration Date: 2031-05-11
- underlying Security Title: Common Stock
- underlying Security Shares: 41667
- shares Owned Following Transaction: 41667
- direct Or Indirect Ownership: D
Convertible Promissory Note (before amendment) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 458334
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Convertible Promissory Note (before amendment)
- id: F3
- id: F5
- conversion Or Exercise Price: 12.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 458334
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-04-17
- expiration Date: 2027-10-17
- underlying Security Title: Common Stock
- underlying Security Shares: 458334
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sequence LifeScience, Inc.
- id: F5
Convertible Promissory Note (as amended) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- A
- Action
- Grant or award
- Quantity
- 1000000
- Price
- Not stated (see footnotes)
- Following holdings
- 1,000,000
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Convertible Promissory Note (as amended)
- id: F3
- id: F4
- id: F5
- conversion Or Exercise Price: 5.50
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 1000000
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-04-17
- expiration Date: 2027-10-17
- underlying Security Title: Common Stock
- underlying Security Shares: 1000000
- shares Owned Following Transaction: 1000000
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sequence LifeScience, Inc.
- id: F5
Existing Warrant (before amendment) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- D
- Action
- Disposition to issuer
- Quantity
- 229167
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Existing Warrant (before amendment)
- id: F3
- id: F5
- conversion Or Exercise Price: 16.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: D
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 229167
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-04-17
- expiration Date: 2031-04-17
- underlying Security Title: Common Stock
- underlying Security Shares: 229167
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sequence LifeScience, Inc.
- id: F5
Existing Warrant (as amended) (derivative)
- Owner
- Kieser Brian Joseph
- Date
- 2026-11-10
- Code
- A
- Action
- Grant or award
- Quantity
- 229167
- Price
- Not stated (see footnotes)
- Following holdings
- 229,167
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Existing Warrant (as amended)
- id: F3
- id: F5
- conversion Or Exercise Price: 13.00
- transaction Date: 2026-11-10
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 229167
- id: F3
- transaction Acquired Disposed Code: A
- exercise Date: 2026-04-17
- expiration Date: 2031-04-17
- underlying Security Title: Common Stock
- underlying Security Shares: 229167
- shares Owned Following Transaction: 229167
- direct Or Indirect Ownership: I
- nature Of Ownership: By Sequence LifeScience, Inc.
- id: F5
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kieser Brian Joseph: Interim CEO, Director, 10% owner.
- F1: Reflects the purchase by Sequence LifeScience, Inc. ("Sequence") on November 10, 2026 of 133,216 units from the Issuer, each unit consisting of one share of Common Stock and a warrant to purchase one share of Common Stock (the "PIPE Warrant"), at $5.50 per unit, in a private placement under a Securities Purchase Agreement. No separate consideration was paid for the PIPE Warrant. The closing occurred on November 10, 2026. The PIPE Warrant has an original issue date of November 10, 2026, is exercisable for cash at $10.00 per share, and expires on the fifth anniversary of its original issue date. The Issuer has waived the beneficial-ownership limitation that would otherwise apply to these securities.
- F2: Share and underlying-share amounts reflect the 1-for-20 reverse stock split of the Issuer's common stock effective October 12, 2026.
- F3: On November 10, 2026, the Reporting Person and Sequence entered into Note Amendment and Conversion Agreements with the Issuer that, among other things, reduced the conversion price of each Convertible Promissory Note from $12.00 to $5.50 per share and the exercise price of each Existing Warrant from $16.00 to $13.00 per share. The amendments are reported as the disposition of the original derivative security and the acquisition of the amended derivative security. The original securities are treated as disposed of solely for purposes of this Form 4 reporting; they were amended and remain outstanding as amended. The transactions were approved in advance by the Issuer's Board of Directors on November 10, 2026 for purposes of Rule 16b-3(d) and (e). Share amounts reflect the 1-for-20 reverse stock split effective October 12, 2026. The Note and Existing Warrant held directly were issued on May 11, 2026, and those held by Sequence were issued on April 17, 2026.
- F4: The conversion price is subject to reset on the first anniversary of issuance and at maturity. The Note converts at the Issuer's closing of the contemplated merger or earlier at the holder's election, subject to the Exchange Cap.
- F5: The securities are held of record by Sequence. The Reporting Person is the indirect sole owner of Sequence and may be deemed to have voting and investment power over the securities held by Sequence. The Reporting Person disclaims beneficial ownership of the securities held by Sequence except to the extent of his pecuniary interest therein.
Original sources
Prepared automatically from public filing data. Report a correction.